MentionFox
Home › Stakes › Maravai Lifesciences Holdings, Inc.
5%+ stakes · Schedule 13D and 13G

Maravai Lifesciences Holdings, Inc.: 5%+ holders

Who has reported owning 5% or more of Maravai Lifesciences Holdings, Inc., from Schedule 13D and 13G filings: each holder's stake as filed, the timeline, and the purpose each 13D states, quoted.

At 5% or more1
Filings12
Latest filing2026-08-13

Maravai Lifesciences Holdings, Inc. has 12 Schedule 13D or 13G filings on record since 2025-07-29. 1 holder's latest filing reports 5% or more of class a common stock, par value $0.01 per share. Each figure below is the holder's own, as filed, with the filing linked.

Holders

HolderPercentSharesLatestEvent date
BlackRock, Inc.5.9%8,580,553SCHEDULE 13G/A, 2025-10-172025-09-30
The Vanguard Group4.92%7,125,498SCHEDULE 13G/A, 2025-10-312025-09-30
12 West Capital Management LP4.9%7,260,195SCHEDULE 13G/A, 2026-05-152026-03-31
Millennium Management LLC4.7%6,900,258SCHEDULE 13G, 2026-06-292026-06-23
Stuart Feldman2.49%3,674,120SCHEDULE 13G/A, 2026-08-132026-06-30

Timeline

FiledHolderPercentFiling
2025-07-29The Vanguard Group6.51%SCHEDULE 13G/A
2025-10-17BlackRock, Inc.5.9%SCHEDULE 13G/A
2025-10-31The Vanguard Group4.92%SCHEDULE 13G/A
2025-11-14Stuart Feldman6.17%SCHEDULE 13G/A
2026-02-13Stuart Feldman5.5%SCHEDULE 13G/A
2026-02-1712 West Capital Management LP6.2%SCHEDULE 13G/A
2026-05-12Millennium Management LLC4.9%SCHEDULE 13G
2026-05-14Stuart Feldman7.06%SCHEDULE 13G/A
2026-05-1512 West Capital Management LP4.9%SCHEDULE 13G/A
2026-06-23Millennium Management LLC4.96%SCHEDULE 13G
2026-06-29Millennium Management LLC4.7%SCHEDULE 13G
2026-08-13Stuart Feldman2.49%SCHEDULE 13G/A

Tools for this story

Each opens in a new tab, filled in for Maravai Lifesciences Holdings, Inc.. With no account yet, you sign up free and land on the result.

Where this comes from

Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.

Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.

Cite this page

Permanent URL: https://mentionfox.com/stakes/maravai-lifesciences-holdings
Last updated 2026-09-27
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
Maravai Lifesciences Holdings, Inc. 5%+ holders: 1 at 5% or more, largest BlackRock, Inc. 5.9%. MentionFox, 2026-09-27. https://mentionfox.com/stakes/maravai-lifesciences-holdings